| dc.contributor.author | Shahab, S. | |
| dc.contributor.author | Sheikhi, M. | |
| dc.contributor.author | Khancheuski, M. | |
| dc.contributor.author | Trifonova, А. | |
| dc.date.accessioned | 2020-11-26T12:37:49Z | |
| dc.date.available | 2020-11-26T12:37:49Z | |
| dc.date.issued | 2020 | |
| dc.identifier.uri | https://rep.bsmu.by/handle/BSMU/29577 | |
| dc.description | Triazavirin – as a potential coronovirus M protease inhibitor 2019-nCoV / S. Shahab [и др.] // Физико-химическая биология как основа современной медицины : тез. докл. участников Респ. конф. с междунар. участием, посвящ. 80-летию со дня рождения Т. С. Морозкиной, Минск, 29 мая 2020 г. / под ред. А. Д. Тагановича, В. В. Хрусталёва, Т. А. Хрусталёвой. – Минск : БГМУ, 2020. – С. 230-232. | ru_RU |
| dc.description.abstract | In 2019, a novel Coronavirus 2019-nCoV was found to cause Severe Acute Respiratory symptoms and rapid pandemic in China, France, United States of America, Germany, Italy, Japan, Russia. In order to find candidate drugs for 2019-nCoV. We have carried out a computational study to screen for effective available drug Triazavirin which may work as inhibitor for the Mpro of 2019-nCoV. | ru_RU |
| dc.language.iso | en | ru_RU |
| dc.publisher | БГМУ | ru_RU |
| dc.subject | Coronavirus | ru_RU |
| dc.title | Triazavirin – as a potential coronovirus M protease inhibitor 2019-nCoV | ru_RU |
| dc.type | Article | ru_RU |
